Vv ECMO Use in COVID-19 Induced Acute Hypoxemic Respiratory Failure

Authors

Andrew Lee, Oakland University William Beaumont School of Medicine Medical Student
Ryan W. Nowatzke, Beaumont Health Resident
Mohammadali Chokr, Beaumont Health Resident
Roy G. Soto, Beaumont Health

Document Type

Conference Proceeding - Restricted Access

Publication Date

10-10-2021

Abstract

We present a 29-year-old female with a history of morbid obesity (BMI 40.40) and PCOS who presented with fever and SOB after testing positive for COVID 3 days prior. She was admitted for treatment of COVID pneumonia and developed acute hypoxic respiratory failure. Despite NIPPV the patient remained hypoxic and she was emergently intubated. SpO2’s remained in the 80’s despite maximal ventilatory therapy and the decision was made to transfer for V-V ECMO cannulation. We will discuss pathophysiology of COVID-19, indications for ECMO, and management of acute hypoxemic respiratory failure.

Comments

American Society of Anesthesiology Annual Meeting, San Diego, CA, October 8-12, 2021.

Recommended Citation

Lee A, Nowatzke RW, Chokr M, Soto RG. Vv ECMO use in COVID-19 induced acute hypoxemic respiratory failure. Paper presented at: The American Society of Anesthesiology Annual Meeting; 2021 Oct 8-12; San Diego, CA. Available at: https://www.abstractsonline.com/pp8/#!/9323/presentation/4761